Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2631439 | Journal of Neonatal Nursing | 2015 | 5 Pages |
Abstract
Studies so far revealed IVIG administration for the prevention of neonatal sepsis being safe resulting in a 3 to 4 percent reduction in nosocomial infections with no significant effect on mortality by meta-analyses. This marginal positive effect has to be discussed in the light of the costs and the values assigned to the clinical outcomes. There is not enough evidence for the use of immunoglobulins in the treatment of bacterial infection in preterm infants. IgM enriched IVIG might be beneficial for extremely low gestational age newborns but up to now meta-analyses do not support its general use in neonates.
Related Topics
Health Sciences
Nursing and Health Professions
Midwifery
Authors
Bernhard (Prof.), Nora MD, Stefan MD,